基于中医“脾”探讨肠道菌群与骨质疏松症的相关性
Exploring the Correlation between Gut Microbiota and Osteoporosis Based on the Concept of the “Spleen” in Traditional Chinese Medicine
DOI: 10.12677/tcm.2025.1410606, PDF,   
作者: 沈阳阳:黑龙江中医药大学研究生院,黑龙江 哈尔滨;杜丽坤*:黑龙江中医药大学附属第一医院内分泌二科,黑龙江 哈尔滨
关键词: 脾(中医)肠道菌群骨质疏松症中医药Spleen (Traditional Chinese Medicine) Gut Microbiota Osteoporosis Traditional Chinese Medicine
摘要: 骨质疏松症是一种全身性代谢性骨病,肠道菌群紊乱被证实为骨质疏松症的致病因素之一。中医“脾”脏与肠道菌群的功能非常相似,中医学理论认为肝脾肾亏虚、血瘀、痰浊均是骨质疏松的病因,其与肠道菌群紊乱导致骨质疏松症的很多机制极为类似,本文对三者之间的关系进行探讨,对“脾”与肠道菌群引起骨质疏松的病因病机进行了概述,以期充分挖掘中医学在骨质疏松症治疗领域的潜力。
Abstract: Osteoporosis is a systemic metabolic bone disease, and gut microbiota dysbiosis has been identified as one of its causative factors. The function of the spleen in Traditional Chinese Medicine (TCM) closely parallels that of the gut microbiota. Traditional Chinese medical theory posits that deficiencies in the liver, spleen, and kidney, blood stasis, and phlegm-dampness are all causative factors of osteoporosis. The mechanisms by which these conditions contribute to osteoporosis are highly analogous to those involving gut microbiota dysbiosis. This paper explores the relationships among these three factors, providing an overview of the pathogenesis of osteoporosis induced by the “spleen” and gut microbiota. The aim is to fully tap into the potential of Traditional Chinese Medicine in the treatment of osteoporosis.
文章引用:沈阳阳, 杜丽坤. 基于中医“脾”探讨肠道菌群与骨质疏松症的相关性[J]. 中医学, 2025, 14(10): 4178-4182. https://doi.org/10.12677/tcm.2025.1410606

参考文献

[1] 原发性骨质疏松症诊疗指南(2022) [J]. 中华骨质疏松和骨矿盐疾病杂志, 2022, 15(6): 573-611.
[2] Ohlsson, C. and Sjögren, K. (2015) Effects of the Gut Microbiota on Bone Mass. Trends in Endocrinology & Metabolism, 26, 69-74. [Google Scholar] [CrossRef] [PubMed]
[3] 邵铁娟, 李海昌, 谢志军, 等. 基于脾主运化理论探讨脾虚湿困与肠道菌群紊乱的关系[J]. 中华中医药杂志, 2014, 29(12): 3762-3765.
[4] 李秋明, 张亚杰, 张大方, 等. 健脾止泻颗粒对脾虚证及抗生素肠道菌群失调模型小鼠的微生态调节作用[J]. 中国中医基础医学杂志, 2010, 16(12): 11191120.
[5] 殷彤彤, 张童茜, 李维辛. 老年女性相对骨骼肌质量指数与骨密度及脂肪含量的相关性[J]. 中国骨质疏松杂志, 2022, 28(1): 43-46.
[6] Haase, S., Haghikia, A., Wilck, N., Müller, D.N. and Linker, R.A. (2018) Impacts of Microbiome Metabolites on Immune Regulation and Autoimmunity. Immunology, 154, 230-238. [Google Scholar] [CrossRef] [PubMed]
[7] 吴秀, 周联, 罗霞, 等. 四君子汤多糖对脾虚小鼠肠道菌群及免疫功能的影响[J]. 中药药理与临床, 2014, 30(2): 12-14.
[8] Weaver, C.M. (2015) Diet, Gut Microbiome, and Bone Health. Current Osteoporosis Reports, 13, 125-130. [Google Scholar] [CrossRef] [PubMed]
[9] 李路娇, 李梅. 肠道菌群与骨骼代谢[J]. 中华骨质疏松和骨矿盐疾病杂志, 2018, 11(3): 317-322.
[10] Liu, J., Chen, Y. and Luo, Q. (2022) The Association of Serum Total Bile Acids with Bone Mineral Density in Chinese Adults Aged 20-59: A Retrospective Cross-Sectional Study. Frontiers in Endocrinology, 13, Article 817437. [Google Scholar] [CrossRef] [PubMed]
[11] Zhao, Y., Song, Y., Zhang, L., Zheng, F., Wang, X., Zhuang, X., et al. (2020) Association between Bile Acid Metabolism and Bone Mineral Density in Postmenopausal Women. Clinics, 75, e1486. [Google Scholar] [CrossRef] [PubMed]
[12] 陈宇航, 许云腾, 张欣, 等. 肠道菌群-胆汁酸在骨质疏松骨代谢紊乱中的研究[J]. 中国骨质疏松杂志, 2024, 30(5): 761-767.
[13] Villa, C.R., Ward, W.E. and Comelli, E.M. (2015) Gut Microbiota-Bone Axis. Critical Reviews in Food Science and Nutrition, 57, 1664-1672. [Google Scholar] [CrossRef] [PubMed]
[14] 李平, 林煜, 朱曦, 等. 补肾健脾方影响高脂肪饮食骨质疏松模型大鼠脂代谢及瘦素的变化[J]. 中国组织工程研究, 2019, 23(3): 470-475.
[15] 廖荣臻, 陈德骏, 何敏聪, 等. 老年性骨质疏松症中医证型与脂代谢中细胞外信号调节激酶的相关性[J]. 中国组织工程研究, 2022, 26(29): 4704-4708.